Document is current
Any future updates will be listed below
-
Authors
Vacca, Michele https://orcid.org/0000-0002-1973-224X
Leslie, Jack https://orcid.org/0000-0001-6443-2396
Virtue, Samuel
Lam, Brian Y. H.
Govaere, Olivier https://orcid.org/0000-0002-4426-6930
Tiniakos, Dina
Snow, Sophie
Davies, Susan
Petkevicius, Kasparas https://orcid.org/0000-0003-2295-6065
Tong, Zhen
Peirce, Vivian
Nielsen, Mette Juul
Ament, Zsuzsanna https://orcid.org/0000-0002-0316-4348
Li, Wei https://orcid.org/0000-0002-1924-3120
Kostrzewski, Tomasz https://orcid.org/0000-0001-6309-628X
Leeming, Diana Julie
Ratziu, Vlad
Allison, Michael E. D.
Anstee, Quentin M. https://orcid.org/0000-0002-9518-0088
Griffin, Julian L.
Oakley, Fiona
Vidal-Puig, Antonio https://orcid.org/0000-0003-4220-9577
-
Funding
Funding for this research was provided by:
Fondazione Umberto Veronesi (Post-Doctoral Fellowship)
DH | National Institute for Health Research (Pump-Priming Grant NIHR-BRC Cambridge Gastro, NIHR Cambridge Biomedical Research Centre)
EC | Horizon 2020 Framework Programme (GA 634413, GA 634413, GA 634413, GA 634413, GA 634413, GA 634413, GA 634413, GA 634413, GA 634413)
RCUK | Medical Research Council (MC_PC_13030, PO 4050281695, MC UP A90 1006, MC_PC_13030, MR/K0019494/1 & MR/R023026/1, PO 4050281695, MRC DMC MC UU 12012/2, MC_PC_13030)
Cancer Research UK (C18342/A23390)
Evelyn Trust
- License Information
-
More Information
Article History
Received: 2 January 2020
Accepted: 24 April 2020
First Online: 8 June 2020
Competing interests
: At the time of this study, T.K. and S.S. were employees of CN Bio Innovations; M.J.N. and D.J.L. of Nordic Bioscience and are among original inventors and patent holders for the PRO-C3, C3M and MMP9 assays. F.O. is a director of Fibrofind. J.L. and F.O. are shareholders in Fibrofind. The other authors declare no competing interests.
